Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/06/2012 | WO2012167192A2 Methods and products for producing engineered mammalian cell lines with amplified transgenes |
12/06/2012 | WO2012166978A2 Fertilization and fruit size |
12/06/2012 | WO2012166964A1 Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production |
12/06/2012 | WO2012166626A1 Reagents and methods for treating dental disease |
12/06/2012 | WO2012166579A1 Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancer |
12/06/2012 | WO2012166408A2 Genetically modified e. coli strains for producing erythromycin analogs |
12/06/2012 | WO2012166049A1 MICROSOMAL ω6 OLEATE DESATURASES |
12/06/2012 | WO2012165961A1 Pest resistant plants |
12/06/2012 | WO2012165927A2 Secretory fusion protein for target tracking |
12/06/2012 | WO2012165925A2 Anti-c-met antibody having hgf activity and use thereof |
12/06/2012 | WO2012165854A2 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
12/06/2012 | WO2012165737A1 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
12/06/2012 | WO2012165714A1 Gene associated with non-biological stress resistance, and transformed plant |
12/06/2012 | WO2012165682A1 Bone forming peptide 4 for promoting osteogenesis or vascularization and use thereof |
12/06/2012 | WO2012165678A1 Oshmb4 gene derived from oryza sativa, and use thereof |
12/06/2012 | WO2012165653A1 Improved oligonucleotide and pharmaceutical composition containing said oligonucleotide |
12/06/2012 | WO2012165627A1 Primer set and method for homologous recombination |
12/06/2012 | WO2012165626A1 Uracil-requiring moorella bacteria and transforming-gene-introduced moorella bacteria |
12/06/2012 | WO2012165616A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION |
12/06/2012 | WO2012165577A1 Novel cellulase derived from thermosporothrix hazakensis |
12/06/2012 | WO2012165544A1 Protein a mutant protein having reduced affinity in acidic region, and antibody capture agent |
12/06/2012 | WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
12/06/2012 | WO2012165407A1 Method for screening for therapeutic agent for cartilage diseases, and genetically modified cartilage cell for use in treatment of cartilage diseases |
12/06/2012 | WO2012165287A1 Production method for artificial cancer stem cell and induced differentiation method therefor |
12/06/2012 | WO2012165270A1 Gene targeting vector, method for manufacturing same, and method for using same |
12/06/2012 | WO2012165131A1 Novel marine microorganism, and method for producing polyhydroxyalkanoate |
12/06/2012 | WO2012164936A1 Suv39h2 as a target gene for cancer therapy and diagnosis |
12/06/2012 | WO2012164933A1 Improved nitrile hydratase |
12/06/2012 | WO2012164565A1 Compositions and methods for downregulating prokaryotic genes |
12/06/2012 | WO2012164130A1 Deficient cell construct in a negative influenza virus modulator for increasing vaccine virus production |
12/06/2012 | WO2012164100A2 Transcription terminator sequences |
12/06/2012 | WO2012164083A1 Polycistronic expression system for bacteria |
12/06/2012 | WO2012164058A1 Methods for adjusting expression of mitochondrial genome by microrna |
12/06/2012 | WO2012163855A1 Expression vectors for an improved protein secretion |
12/06/2012 | WO2012163818A1 Means and methods to induce apomixis in plants |
12/06/2012 | WO2012163817A2 Immunogenic composition |
12/06/2012 | WO2012163814A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia |
12/06/2012 | WO2012163811A1 Immunogenic composition |
12/06/2012 | WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
12/06/2012 | WO2012163119A1 Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power |
12/06/2012 | WO2012163084A1 Novel method for preventing and controlling pests based on rnai technology |
12/06/2012 | WO2012162840A1 Polysaccharide-based hydrogel polymer and uses thereof |
12/06/2012 | WO2012142238A3 Compositions and methods for the treatment of tissue fibrosis |
12/06/2012 | WO2012139002A3 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer |
12/06/2012 | WO2012138223A3 Compounds and methods for altering activin receptor-like kinase signalling |
12/06/2012 | WO2012135736A3 Modulation of signal transducer and activator of transcription 3 (stat3) expression |
12/06/2012 | WO2012115390A3 Method for preparing lactulose from lactose using cellobiose 2-epimerase or n-acetyl glucosamin 2-epimerase |
12/06/2012 | WO2012106281A3 Multimodal trail molecules and uses in cellular therapies |
12/06/2012 | WO2012103385A3 Biocatalysts synthesizing deregulated cellulases |
12/06/2012 | WO2012100027A3 Epigenetic biomarkers for liver disease |
12/06/2012 | WO2012099396A3 A microorganism having enhanced l-amino acids productivity and process for producing l-amino acids using the same |
12/06/2012 | WO2012096523A3 Detection of target nucleic acid sequences by pto cleavage and extension assay |
12/06/2012 | WO2012092376A3 Comprehensive monoclonal antibody generation |
12/06/2012 | WO2012088071A3 Designer calvin-cycle-channeled and hydrogenotrophic production of butanol and related higher alcohols |
12/06/2012 | WO2012051567A3 Obesity-related genes and their proteins and uses thereof |
12/06/2012 | WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
12/06/2012 | US20120311746 Insect resistance management with combinations of cry1be and cry1f proteins |
12/06/2012 | US20120311743 Soybean transformation using hppd inhibitors as selection agents |
12/06/2012 | US20120311742 Method for modifying plant morphology, biochemistry and physiology |
12/06/2012 | US20120311741 Sophorolipid transporter protein |
12/06/2012 | US20120311740 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
12/06/2012 | US20120311739 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
12/06/2012 | US20120311738 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
12/06/2012 | US20120311737 Induction of apomixis in sexually reproducing cultivated plants and use for producing totally or partially apomictic plants |
12/06/2012 | US20120311734 Potato transformation compositions, systems, methods, microorganisms, and plants |
12/06/2012 | US20120309951 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis |
12/06/2012 | US20120309950 Phosphatidic acid phosphatase gene and use thereof |
12/06/2012 | US20120309942 Fully humanized anti-her2 antibody, preparation method and use thereof |
12/06/2012 | US20120309940 Glycosylated repeat-motif-molecule conjugates |
12/06/2012 | US20120309936 Reducing the immunogenicity of fusion proteins |
12/06/2012 | US20120309935 Method of reducing glycosylation of proteins, processes and proteins thereof |
12/06/2012 | US20120309918 Polypeptides having oxidoreductase activity and their uses |
12/06/2012 | US20120309817 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
12/06/2012 | US20120309816 Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo |
12/06/2012 | US20120309815 Compositions and methods for topical delivery of oligonucleotides |
12/06/2012 | US20120309813 DELIVERY OF dsRNA TO ARTHROPODS |
12/06/2012 | US20120309689 Hatching fluid enzymes and uses thereof |
12/06/2012 | US20120309684 Conjugates for delivery of biologically active compounds |
12/06/2012 | US20120309675 Peptide bfp4 for promoting osteogenesis or vascularization and use thereof |
12/06/2012 | US20120309093 Method for preparing xylose-utilizing strain |
12/06/2012 | US20120309092 Angiogenin Expression in Plants |
12/06/2012 | US20120309091 Methods And Compositions For Gene Inactivation |
12/06/2012 | US20120309085 Variant Forms of Urate Oxidase and Use Thereof |
12/06/2012 | US20120309073 Rnai in budding yeast |
12/06/2012 | US20120309067 Protease Variants |
12/06/2012 | US20120309065 Thermophilic thermoanaerobacter italicus subsp. marato having high alcohol productivity |
12/06/2012 | US20120309064 Mutant delta-5 desaturases mutated in the heme-binding motif (hpgg) and their use in making polyunsaturated fatty acids |
12/06/2012 | US20120309062 Microorganisms for the production of adipic acid and other compounds |
12/06/2012 | US20120309059 Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same |
12/06/2012 | US20120309052 Inducible baculovirus system in insect cells |
12/06/2012 | US20120309051 Compositions and methods for preparing recombinant mg53 and methods for optimizing same |
12/06/2012 | US20120309050 System for increasing gene expression and vector comprising the system |
12/06/2012 | US20120309032 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection |
12/06/2012 | US20120309031 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
12/06/2012 | US20120309000 Mycobacteria-derived dna mismatch repair nucleotide sequences and uses thereof |
12/06/2012 | US20120308995 Vaccinia virus mutants containing the major genomic deletions of mva |
12/06/2012 | US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha |
12/06/2012 | US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function |
12/06/2012 | US20120308603 Dna vaccine against virus of yellow fever |
12/06/2012 | US20120308602 Recombinant RSV Virus Expression Systems And Vaccines |